Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;133(17-18):983-988.
doi: 10.1007/s00508-021-01855-6. Epub 2021 Apr 20.

Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients

Antonio Vitiello  1 , Francesco Ferrara  2
Affiliations

Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients

Antonio Vitiello et al. Wien Klin Wochenschr. 2021 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

A. Vitiello and F. Ferrara declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Mechanism of action: sacubitril/valsartan association is neprilysin inhibitor and angiotensin II receptor blocker type‑1 (AT-1 r). The complementary cardiovascular benefits of sacubitril/valsartan are attributed to the increase in neprilysin-degraded peptides and the simultaneous inhibition of the effects of angiotensin II. ANP atrial natriuretic peptide, BNP B-type natriuretic peptide, CNP C-type natriuretic peptide, ANG I Angiotensin I, ANG II Angiotensin II
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. McMichael TM, Currie DW, Clark S, Pogosjans S, Kay M, Schwartz NG, et al. Public health—seattle and king county, evergreenhealth, and CDC COVID-19 investigation team. Epidemiology of Covid-19 in a long-term care facility in king county, washington. N Engl J Med. 2020;382(21):2005–2011. doi: 10.1056/NEJMoa2005412. - DOI - PMC - PubMed
    1. Ferrara F, Porta R, D’Aiuto V, Vitiello A. Remdesivir and COVID-19. Ir J Med Sci. 2020;17:1–2. doi: 10.1007/s11845-020-02401-5. - DOI - PMC - PubMed
    1. World health organization (WHO). Situation Reports July 2020. https://www.who.int/emergencies/diseases/novelcoronavirus2019/situation-.... Accessed 2 March 2021
    1. Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. StatPearls. 2020. Features, evaluation, and treatment of Coronavirus. - PubMed
    1. Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-coV-2 spike glycoprotein. Cell. 2020;181(2):281–292.e6. doi: 10.1016/j.cell.2020.02.058. - DOI - PMC - PubMed

MeSH terms

Substances

LinkOut - more resources